FK 506 ameliorates normothermic liver ischemia in rats by suppressing production of tumor necrosis factor

  • Katsunori Kawano
  • Yang KimII
  • Shigeru Goto
  • Tetsuji Kai
  • Michio Kobayashi
  • Tatsuo Shimada
  • Naoshi Kamada
Conference paper


In recent years, there has been growing evidence that tumor necrosis fact or-a: (TNF) plays an important role in the development of hepatic injury after ische-mia-reperfusion. We have previously demonstrated that the immunosuppressants, cyclosporine, azathioprine and FK506 (FK), have a protective effect on warm ischemic injury of the rat liver. In the present study, we attempted to elucidate the mechanism for the beneficial effect of FK on liver ischemia, with special reference to the suppression of TNF production. After 60 min and 90 min of warm liver ischemia, the survival rates were significantly improved by FK pretherapy. This was associated with amelioration of hepatic injury, as assessed by histological examinations and determinations of serum AST and lipid peroxide levels in the liver. After 60 min of liver ischemia, TNF was measurable during the reperfusion period in the sera of the control animals, peaking of 6h after reperfusion (123 ± 15.8 pg/ml, mean SEM). In contrast, pretreatment with FK significantly suppressed the elevation of serum TNF levels at the same time point (75.8 ± 13.1 pg/ml, P<0.05). The present data showed that liver ischemia-reperfusion resulted in TNF production, and that FK could protect the liver from reperfusion injury by suppressing this production of TNF.

Key words

Liver ischemia FK506 Lipid peroxidation Tumor necrosis factor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shaw B W, Wood RP (1989) Improved results with retransplanta-tion of the liver. Transplant Proc 21:2407–2408PubMedGoogle Scholar
  2. 2..
    Howard TK, Klintmalm GBG, Gofer JB, Husberg BS, Goldstein RM, Gonwa TA (1990) The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 49: 103–107PubMedCrossRefGoogle Scholar
  3. 3.
    Kawano K, Kim YI, Katetani K, Kobayashi M (1989) The beneficial effect of cyclosporine on liver ischemia in rats. Transplantation 48:759–764PubMedCrossRefGoogle Scholar
  4. 4.
    Kawano K, Kim YI, Goto S, et al (1990) Evidence that azathi-prine, as well as cyclosporine, ameliorates warm ischemia in the rat liver. Transplantation 49:1002–1003PubMedCrossRefGoogle Scholar
  5. 5.
    Kim YI, Kawano K, Goto S, et al (1991) Beneficial effect of pre-treatment with azathioprine on warm and cold ischemia of the swine liver. Transplant Proc 23:2201–2203PubMedGoogle Scholar
  6. 6.
    Goto S, Kim YI, Kamada N, Kawano K, Kobayashi M (1990) The beneficial effect of pretransplant cyclosporine therapy on recipient rats grafted with a 12-hour cold-stored liver. Transplantation 49:1003–1004PubMedCrossRefGoogle Scholar
  7. 7.
    Kawano K, Kim YI, Goto S, Ono M, Kabayashi M (1991) A protective effect of FK506 in ischemically injured rat livers. Transplantation 52:143–145PubMedCrossRefGoogle Scholar
  8. 8.
    Sakr MF, Zetti GM, Farghali H, et al (1991) Protective effect of FK 506 against hepatic ischemia in rats. Transplant Proc 23:340–341PubMedGoogle Scholar
  9. 9.
    Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 95: 351–358PubMedCrossRefGoogle Scholar
  10. 10.
    Lowry OH, Rosebrough NJ, Lewis Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  11. 11.
    McCord JM (1985) Oxygen derived free radicals in post-ischemic tissue injury. N Engl J Med 312:159–163PubMedCrossRefGoogle Scholar
  12. 12.
    Marubayashi S, Dohi K, Ochi K, Kawasaki T (1986) Role of free radicals in ischemic rat liver cell injury: prevention of damage by a-tocopherol administration. Surgery 99:184–192PubMedGoogle Scholar
  13. 13.
    Southard JH, Marsh DC, McAnulty JF, Belzer FO (1987) Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery 101:566–570PubMedGoogle Scholar
  14. 14.
    Shiratori Y, Kawase T, Shiina S, et al (1988) Modulation of hepa-totoxicity by macrophages in the liver. Hepatology 8:815–821PubMedCrossRefGoogle Scholar
  15. 15.
    Arthur MJP, Kowalski-Saunders P, Wright R (1988) Effect of endotoxin on release of reactive oxygen intermediates by rat hepatic macrophages. Gastroenterology 95:1588–1594PubMedGoogle Scholar
  16. 16.
    Nathan CF (1987) Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80:1550–1560PubMedCrossRefGoogle Scholar
  17. 17.
    Goldin H, Keisari Y (1989) The effect of cyclosporine on macrophage oxidative burst potential during graft-versus-host reactions in mice. Transplantation 47:548–552PubMedCrossRefGoogle Scholar
  18. 18.
    Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA (1990) Role of tumor necrosis factor in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936–1943PubMedCrossRefGoogle Scholar
  19. 19.
    Schlayer HJ, Laaff H, Peters T, et al (1988) Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 7:239–249PubMedCrossRefGoogle Scholar
  20. 20.
    Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gim-brone MA (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium. Proc Natl Acad Sci USA 83:4533–537PubMedCrossRefGoogle Scholar
  21. 21.
    Nawroth PP, Stern DM (1986) Modulation of endothelial-cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745PubMedCrossRefGoogle Scholar
  22. 22.
    Varani J, Bendelow MJ, Sealey DE, et al (1988) Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Lab Invest 59:292–295PubMedGoogle Scholar
  23. 23.
    Tocci MJ, Matkovichr DA, Collier KA, et al (1989) The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 143:718–726PubMedGoogle Scholar
  24. 24.
    Starzl TE, Porter KA, Mazzaferro V, Todo S, Fung J, Francavilla A (1991) Hepatotrophic effects of FK506 in dogs. Transplantation 51:67–70PubMedCrossRefGoogle Scholar
  25. 25.
    Francavilla A, Barone M, Starzl TE, et al (1990) FK506 as a growth control factor. Transplant Proc 23:90–92Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • Katsunori Kawano
    • 1
  • Yang KimII
    • 1
  • Shigeru Goto
    • 1
  • Tetsuji Kai
    • 1
  • Michio Kobayashi
    • 1
  • Tatsuo Shimada
    • 2
  • Naoshi Kamada
    • 3
  1. 1.Departments of Surgery IOitaJapan
  2. 2.Department of AnatomyOita Medical CollegeOitaJapan
  3. 3.Department of Experimental SurgeryNational Children’s Medical Research CenterTokyo, 154Japan

Personalised recommendations